The Publisher apologises for three errors in the author affiliations in the article. These have been corrected in the published article, as follows:
1Faculty of Pharmacy, Université Laval, Québec City, QC, Canada; 2Department of Oncology, CHU de Québec-Université Laval Research Center, Québec City, QC, Canada; 3Institut de soins palliatifs et de fin de vie Michel-Sarrazin — Université Laval, Québec City, QC, Canada; 4Réseau québécois de recherche en soins palliatifs et de fin de vie (RQSPAL), Québec, QC, Canada; 5Faculty of Medicine, Université Laval, Québec City, QC, Canada; 6Patient-Partner and 7Department of Population Health and Optimal Health Practices, CHU de Québec-Université Laval Research Center, Québec City, QC, Canada.
Reference
- Dorval M, Audet-Croteau V, Chang S-L, Moureaux F, Guertin JR. End of life distress as an economic issue: The case for psychedelic-assisted therapy. Palliative and Supportive Care. Published by Cambridge University Press, 28 January 2026. doi: 10.1017/S1478951526101722 [DOI] [PMC free article] [PubMed] [Google Scholar]
